Newer Biologics Tied to Fewer Infections for Older Patients With Psoriatic Disease

MedPage Today) — Biologics targeting interleukin (IL)-12, IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a Canadian cohort study showed.
For more than 11,000 older adults started…